Table 1. Overview about patient characteristics at the time of chemotherapy (n=28).

Parameter	Mean	Median	Range
Age (years)	70.7	72	48–82
PSA start CTX (ng/mL)	73.3	10.4	0.5–978.8
Time surgery: mCRPC (months)	131	86	8–220
Number of CTX cycles	7.5	6	3–10
PSA nadir during CTX (ng/mL)	31.9	2.18	0.0–431.7

mCRPC, metastatic castration resistant prostate cancer; CTX, chemotherapy; PSA, prostate specific antigen.